Use of acetyl D-carnitine in the therapeutic treatment of glauco

Details Use of acetyl D-carnitine in the therapeutic treatment of glauco Use of acetyl D-carnitine in the therapeutic treatment of glauco

1991-04-23

1995-07-11

Fay, Zohreh

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514913, A61K 3122

Patent

active

054321999

ABSTRACT:
The use is described of acetyl D-carnitine and its pharmacologically acceptable salts in the therapeutic treatment of glaucoma. The medicament may be administered orally or parenterally or be applied as a collyrium containing approximately 1-10% w/v of acetyl D-carnitine.

REFERENCES:
patent: 4724230 (1988-02-01), Cone, Jr.

Affiliated with

Also associated with

Rating

Use of acetyl D-carnitine in the therapeutic treatment of glauco does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of acetyl D-carnitine in the therapeutic treatment of glauco, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of acetyl D-carnitine in the therapeutic treatment of glauco will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-503784